Insider Trading activities of Collagenex Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Collagenex Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Collagenex Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Collagenex Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is CGPI. The reporting company's CIK number is 1012270.
The total value of stock buying since 2005 is $196,197.
The total value of stock sales since 2005 is $2,201,228.
The total value of stock option exercises since 2005 is $1,905,483.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Collagenex Pharmaceuticals Inc (CGPI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2008-02 0 $0 6,667 $81,870 23,334 $145,836
2008-01 0 $0 26,667 $308,797 26,667 $166,666
2007-11 5,200 $40,354 0 $0 0 $0
2007-08 0 $0 8,333 $110,412 8,333 $52,081
2007-07 0 $0 30,000 $383,130 30,000 $318,750
2007-06 0 $0 30,000 $366,340 30,000 $318,750
2007-05 200 $2,096 0 $0 0 $0
2007-04 0 $0 5,000 $71,150 5,000 $32,300
2006-11 0 $0 16,667 $233,337 46,667 $442,503
2006-09 0 $0 49,433 $646,192 33,333 $299,997
2006-06 0 $0 0 $0 10,000 $128,600
2005-06 30,800 $153,747 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Collagenex Pharmaceuticals Inc insiders (CGPI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-02-08 Broadbent Nancy C (CFO and Treasurer) Option Ex 16,667 6.25 104,168
2008-02-04 Pfeiffer David F (Sr. VP, Sales and Marketing) Sale 6,667 12.28 81,870
2008-02-04 Pfeiffer David F (Sr. VP, Sales and Marketing) Option Ex 6,667 6.25 41,668
2008-01-28 Pfeiffer David F (Sr. VP, Sales and Marketing) Sale 13,334 11.81 157,514
2008-01-28 Pfeiffer David F (Sr. VP, Sales and Marketing) Option Ex 13,334 6.25 83,336
2008-01-22 Pfeiffer David F (Sr. VP, Sales and Marketing) Sale 6,666 10.88 72,526
2008-01-22 Pfeiffer David F (Sr. VP, Sales and Marketing) Option Ex 6,666 6.25 41,662
2007-11-28 Powell Andrew Kenneth William (VP, G. Counsel and Corp. Sec.) Buy 200 7.30 1,460
2007-11-28 Theobald Klaus (Sr VP & Chief Medical Officer) Buy 1,050 7.41 7,780
2007-11-27 Theobald Klaus (Sr VP & Chief Medical Officer) Buy 300 7.41 2,223
2007-11-20 Ford James Gregory (VP, Business Development) Buy 1,500 7.87 11,805
2007-11-20 Theobald Klaus (Sr VP & Chief Medical Officer) Buy 1,300 7.75 10,071
2007-11-16 Powell Andrew Kenneth William (VP, G. Counsel and Corp. Sec.) Buy 400 8.01 3,204
2007-11-08 Powell Andrew Kenneth William (VP, G. Counsel and Corp. Sec.) Buy 450 8.47 3,811
2007-08-09 Broadbent Nancy C (CFO and Treasurer) Sale 8,333 13.25 110,412
2007-08-09 Broadbent Nancy C (CFO and Treasurer) Option Ex 8,333 6.25 52,081
2007-07-16 Pfeiffer David F (Sr. VP, Sales and Marketing) Sale 10,000 12.65 126,510
2007-07-16 Pfeiffer David F (Sr. VP, Sales and Marketing) Option Ex 10,000 10.62 106,250
2007-07-09 Pfeiffer David F (Sr. VP, Sales and Marketing) Sale 10,000 12.87 128,680
2007-07-09 Pfeiffer David F (Sr. VP, Sales and Marketing) Option Ex 10,000 10.62 106,250
2007-07-02 Pfeiffer David F (Sr. VP, Sales and Marketing) Sale 10,000 12.79 127,940
2007-07-02 Pfeiffer David F (Sr. VP, Sales and Marketing) Option Ex 10,000 10.62 106,250
2007-06-25 Pfeiffer David F (Sr. VP, Sales and Marketing) Sale 10,000 12.35 123,510
2007-06-25 Pfeiffer David F (Sr. VP, Sales and Marketing) Option Ex 10,000 10.62 106,250
2007-06-18 Pfeiffer David F (Sr. VP, Sales and Marketing) Sale 10,000 12.24 122,420
2007-06-18 Pfeiffer David F (Sr. VP, Sales and Marketing) Option Ex 10,000 10.62 106,250
2007-06-11 Pfeiffer David F (Sr. VP, Sales and Marketing) Sale 10,000 12.04 120,410
2007-06-11 Pfeiffer David F (Sr. VP, Sales and Marketing) Option Ex 10,000 10.62 106,250
2007-05-22 Powell Andrew Kenneth William (VP, G. Counsel and Corp. Sec.) Buy 200 10.48 2,096
2007-04-19 Ford James Gregory (VP, Business Development) Sale 5,000 14.23 71,150
2007-04-19 Ford James Gregory (VP, Business Development) Option Ex 5,000 6.46 32,300
2006-11-09 Easton Robert J Option Ex 15,000 9.75 146,250
2006-11-09 Daverman James E Option Ex 15,000 9.75 146,250
2006-11-07 Broadbent Nancy C (CFO and Treasurer) Sale 8,334 14.25 118,759
2006-11-07 Broadbent Nancy C (CFO and Treasurer) Option Ex 8,334 9.00 75,006
2006-11-06 Broadbent Nancy C (CFO and Treasurer) Sale 8,333 13.75 114,578
2006-11-06 Broadbent Nancy C (CFO and Treasurer) Option Ex 8,333 9.00 74,997
2006-09-26 Broadbent Nancy C (CFO and Treasurer) Sale 6,132 13.25 81,249
2006-09-26 Broadbent Nancy C (CFO and Treasurer) Option Ex 6,132 9.00 55,188
2006-09-25 Broadbent Nancy C (CFO and Treasurer) Sale 2,201 13.25 29,163
2006-09-25 Broadbent Nancy C (CFO and Treasurer) Option Ex 2,201 9.00 19,809
2006-09-19 Daverman James E Sale 13,000 13.06 169,780
2006-09-18 Easton Robert J Sale 10,000 13.07 130,700
2006-09-15 Barnett Peter R Sale 18,100 13.00 235,300
2006-09-15 Barnett Peter R Option Ex 25,000 9.00 225,000
2006-06-05 Easton Robert J Option Ex 10,000 12.86 128,600
2005-06-15 Daverman James E (Director) Buy 20,000 5.03 100,640
2005-06-13 Powell Andrew Kenneth William (VP, G. Counsel and C) Buy 1,800 4.86 8,757
2005-06-10 Stewart Colin W (President and CEO) Buy 5,000 4.95 24,750
2005-06-10 Pfeiffer David F (Sr. VP, Sales and Ma) Buy 4,000 4.90 19,600

Insider trading activities including stock purchases, stock sales, and option exercises of CGPI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Collagenex Pharmaceuticals Inc (symbol CGPI, CIK number 1012270) see the Securities and Exchange Commission (SEC) website.